Ubie vs Lunit
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Ubie
Japan's AI symptom checker — 20 questions, 3 minutes, no signup
Visit
|
Lunit
KOSDAQ-listed Korean AI for breast and lung cancer screening
Visit
|
|
|---|---|---|
| RECATOOLS Score | 7.8 / 10 | 6.7 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Freemium | Enterprise |
| Free tier | Core symptom checker free, no registration required | — |
| Paid from | Medical Navigator (AI問診) B2B is quote-based, not publicly disclosed | — |
| Has API | ✗ | ✗ |
| Open source | ✗ | ✗ |
| Free to use | ✓ | ✗ |
| Users | 10M+ monthly users globally; 1,800+ medical institutions in Japan (2025) | — |
| Founded | 2017 | 2013 |
| Maker | Ubie, Inc. | — |
| Verdict | Ubie clears a bar most AI symptom checkers don't bother with: published, peer-reviewed accuracy data. A 2024 medRxiv vignette study put its top-10 diagnostic hit rate at 71.6%, close to the 72.9% median for physicians on... |
Lunit is the most clinically validated medical-AI company to come out of Korea, and one of the few in the category with real revenue rather than just pilot deployments — Q1 2026 revenue hit 24 billion won, up nearly 25%... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.